↓ Skip to main content

How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness?

Overview of attention for article published in AMA Journal of Ethics, May 2022
Altmetric Badge

Mentioned by

twitter
3 tweeters
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness?
Published in
AMA Journal of Ethics, May 2022
DOI 10.1001/amajethics.2022.361
Pubmed ID
Authors

Valerie Clinard, Jennifer D. Smith

Abstract

The Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey data reveal that consumption of over-the-counter vitamins, minerals, and herbals is widespread. Many clinicians, however, lack critical information about their patients' use of dietary supplements. Particularly clinically relevant are supplement ingredients' interactions with prescription medications, supplements' questionable effectiveness in treating serious conditions, and their potential for causing harm. This article considers how clinicians might address dietary supplements' safety, efficacy, and appropriate use with patients.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.